![](/img/cover-not-exists.png)
Hematocrit was not validated as a surrogate end point for survival among epoetin-treated hemodialysis patients
Dennis J. Cotter, Kevin Stefanik, Yi Zhang, Mae Thamer, Daniel Scharfstein, James KaufmanVolume:
57
Year:
2004
Language:
english
DOI:
10.1016/j.jclinepi.2004.05.002
File:
PDF, 359 KB
english, 2004